Skip to main navigation Skip to search Skip to main content

Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial

  • Seong Ho Koh
  • , Hyuk Sung Kwon
  • , Seong Hye Choi
  • , Jee Hyang Jeong
  • , Hae Ri Na
  • , Chan Nyoung Lee
  • , Young Soon Yang
  • , Ae Young Lee
  • , Jae Hong Lee
  • , Kyung Won Park
  • , Hyun Jeong Han
  • , Byeong C. Kim
  • , Jin Se Park
  • , Jee Young Lee
  • , Sangjae Kim
  • , Kyu Yong Lee

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry